Correlation Between Redsense Medical and Nexam Chemical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Redsense Medical and Nexam Chemical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Redsense Medical and Nexam Chemical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Redsense Medical AB and Nexam Chemical Holding, you can compare the effects of market volatilities on Redsense Medical and Nexam Chemical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Redsense Medical with a short position of Nexam Chemical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Redsense Medical and Nexam Chemical.

Diversification Opportunities for Redsense Medical and Nexam Chemical

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Redsense and Nexam is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Redsense Medical AB and Nexam Chemical Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nexam Chemical Holding and Redsense Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Redsense Medical AB are associated (or correlated) with Nexam Chemical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nexam Chemical Holding has no effect on the direction of Redsense Medical i.e., Redsense Medical and Nexam Chemical go up and down completely randomly.

Pair Corralation between Redsense Medical and Nexam Chemical

Assuming the 90 days trading horizon Redsense Medical AB is expected to generate 1.23 times more return on investment than Nexam Chemical. However, Redsense Medical is 1.23 times more volatile than Nexam Chemical Holding. It trades about 0.01 of its potential returns per unit of risk. Nexam Chemical Holding is currently generating about 0.0 per unit of risk. If you would invest  936.00  in Redsense Medical AB on September 2, 2024 and sell it today you would lose (226.00) from holding Redsense Medical AB or give up 24.15% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.4%
ValuesDaily Returns

Redsense Medical AB  vs.  Nexam Chemical Holding

 Performance 
       Timeline  
Redsense Medical 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Redsense Medical AB are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Redsense Medical is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Nexam Chemical Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nexam Chemical Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Redsense Medical and Nexam Chemical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Redsense Medical and Nexam Chemical

The main advantage of trading using opposite Redsense Medical and Nexam Chemical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Redsense Medical position performs unexpectedly, Nexam Chemical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nexam Chemical will offset losses from the drop in Nexam Chemical's long position.
The idea behind Redsense Medical AB and Nexam Chemical Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal